Abstract
The “pleiotropic” effects of statins have been the centre of a considerable research activity. Among the numerous experimental and clinical studies of this field, some focused on the effects of statins on blood pressure (BP), while others reported data on BP together with other parameters. Some of the animal or human studies do not show an association between statin treatment and BP changes, whereas others usually report mild but significant reductions. Among the latter, all clinical studies using ambulatory BP recordings show a significant drop in both systolic and diastolic BP in hypertensive patients. In addition, accumulating evidence has identified a number of statin actions that may be involved in BP lowering. Overall, current evidence suggests that statins can be associated with a mild beneficial effect on BP, but further research is needed to clarify the exact magnitude of this action, as well as its clinical relevance.
Keywords: Blood pressure, Statins, HMG-CoA reductase inhibitors, hypertension
Current Vascular Pharmacology
Title: Effects of Statins on Blood Pressure: A Review of the Experimental and Clinical Evidence.
Volume: 5 Issue: 2
Author(s): Pantelis A. Sarafidis, Angeliki I. Kanaki and Anastasios N. Lasaridis
Affiliation:
Keywords: Blood pressure, Statins, HMG-CoA reductase inhibitors, hypertension
Abstract: The “pleiotropic” effects of statins have been the centre of a considerable research activity. Among the numerous experimental and clinical studies of this field, some focused on the effects of statins on blood pressure (BP), while others reported data on BP together with other parameters. Some of the animal or human studies do not show an association between statin treatment and BP changes, whereas others usually report mild but significant reductions. Among the latter, all clinical studies using ambulatory BP recordings show a significant drop in both systolic and diastolic BP in hypertensive patients. In addition, accumulating evidence has identified a number of statin actions that may be involved in BP lowering. Overall, current evidence suggests that statins can be associated with a mild beneficial effect on BP, but further research is needed to clarify the exact magnitude of this action, as well as its clinical relevance.
Export Options
About this article
Cite this article as:
Sarafidis A. Pantelis, Kanaki I. Angeliki and Lasaridis N. Anastasios, Effects of Statins on Blood Pressure: A Review of the Experimental and Clinical Evidence., Current Vascular Pharmacology 2007; 5 (2) . https://dx.doi.org/10.2174/157016107780368307
DOI https://dx.doi.org/10.2174/157016107780368307 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Iatrogenic Right Atrial Thrombus Complicated by Pulmonary Embolism: Management and Outcomes
Current Cardiology Reviews Alzheimers Disease Burdens African-Americans: A Review of Epidemiological Risk Factors and Implications for Prevention and Treatment
Current Psychiatry Reviews Chickpea (Cicer arietinum L.) Lectin Exhibit Inhibition of ACE-I, α-amylase and α-glucosidase Activity
Protein & Peptide Letters Depression and Medication Adherence in Patients on Hemodialysis
Current Hypertension Reviews Oncolytic Coxsackievirus and the Mechanisms of its Effects on Cancer: A Narrative Review
Current Cancer Therapy Reviews The Pathophysiology of Uric Acid in Relation to Cardiovascular Disease
Current Cardiology Reviews Identification of Novel Pancreatic Lipase Inhibitors Using <i>In Silico</i> Studies
Endocrine, Metabolic & Immune Disorders - Drug Targets Endothelial Dysfunction: Methods of Assessment & Implications for Cardiovascular Diseases
Current Pharmaceutical Design Managing Safety Signals in Large Endpoint Trials
Current Drug Safety Effective Delivery of Male Contraceptives Behind the Blood-Testis Barrier (BTB) – Lesson from Adjudin
Current Medicinal Chemistry Linking Alzheimer’s Disease and Type 2 Diabetes Mellitus via Aberrant Insulin Signaling and Inflammation
CNS & Neurological Disorders - Drug Targets Therapeutic Targeting of Endothelial Dysfunction in Chronic Diabetic Complications
Recent Patents on Cardiovascular Drug Discovery The Role of Xanthine Oxidase Inhibitors in Patients with History of Stroke: A Systematic Review
Current Vascular Pharmacology Effect of Black Seed on Dextromethorphan O- and N-Demethylation in Human Liver Microsomes and Healthy Human Subjects
Drug Metabolism Letters Relationship of High-Sensitivity C-Reactive Protein Concentrations and Systolic Heart Failure
Current Vascular Pharmacology Is there a Place for Bevacizumab in Patients with Extensive-Stage Small Cell Lung Cancer?
Current Cancer Drug Targets Patent Selections
Recent Patents on Cardiovascular Drug Discovery Serum Collagen Markers and Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets The “Parkinsonian Heart”: From Novel Vistas to Advanced Therapeutic Approaches in Parkinsons Disease
Current Medicinal Chemistry Diagnosis and New Approaches in the Therapy of Gestational Diabetes Mellitus
Current Diabetes Reviews